Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multicenter, Double Blind, Randomized Placebo Controlled Phase 3 trial (ICR-02/ASCOLT)

drug protocol number
ICR-02/ASCOLT
drug sponsor
King Fahad Medical City
drug study
Aspirin
drug trial site
King Fahad Medical City (Riyadh)
drug status
Ongoing
drug phase